GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigen Vaccine Biologics Corp (ROCO:6547) » Definitions » Policy Acquisition Expense

Medigen Vaccine Biologics (ROCO:6547) Policy Acquisition Expense


View and export this data going back to 2015. Start your Free Trial

What is Medigen Vaccine Biologics Policy Acquisition Expense?

Policy Acquisition Expense only applies to insurance companies.


Medigen Vaccine Biologics Business Description

Traded in Other Exchanges
N/A
Address
No.68, Shengyi 3rd Road, Hsinchu County, Zhubei, TWN, 30261
Medigen Vaccine Biologics Corp is a biopharmaceutical company focusing on developing and producing vaccines and biologics. It is engaged in developing IP-protected cell-culture technologies for vaccine manufacturing. The company develops vaccines and affordable biosimilars to prevent regional infectious diseases. The group generates revenue from manufacturing and selling a range of COVID-19 vaccines and COVID-19 test kits and provides technical services on cellular therapy product quality and cell culture tests.